GSK
GSK
682 hedge funds and large institutions have $14.4B invested in GSK in 2013 Q4 according to their latest regulatory filings, with 95 funds opening new positions, 265 increasing their positions, 204 reducing their positions, and 38 closing their positions.
158% more call options, than puts
Call options by funds: $164M | Put options by funds: $63.5M
150% more first-time investments, than exits
New positions opened: 95 | Existing positions closed: 38
30% more repeat investments, than reductions
Existing positions increased: 265 | Existing positions reduced: 204
15% more funds holding in top 10
Funds holding in top 10: 13 → 15 (+2)
7% more funds holding
Funds holding: 635 → 682 (+47)
7% more capital invested
Capital invested by funds: $13.5B → $14.4B (+$883M)
0.04% more ownership
Funds ownership: 4.38% → 4.42% (+0.04%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$267M |
| 2 |
Renaissance Technologies
New York
|
+$131M |
| 3 |
WHG
Westwood Holdings Group
Dallas,
Texas
|
+$107M |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
+$77M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$68.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$186M |
| 2 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$165M |
| 3 |
Bank of New York Mellon
New York
|
-$80.4M |
| 4 |
EAM
Edge Asset Management
Seattle,
Washington
|
-$75.7M |
| 5 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$56.7M |
GSK Hedge Fund Activity: Q4 2013 in Review
682 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in GSK (GSK) for Q4 2013, worth a combined $14.4B — up 6.5% from $13.5B a quarter earlier.
Buyers outnumbered sellers: 95 funds opened new GSK positions and 38 closed out — a net gain of 57 holders — while 265 added to existing stakes and 204 trimmed.
The largest buyer was Bank of America, adding an estimated $267M. The largest seller was Fidelity Investments, cutting an estimated $186M.
- 682 institutional investors held GSK (GSK) as of Q4 2013, up from 635 in Q3 2013.
- Funds reported $14.4B of GSK stock for Q4 2013, up 6.5% quarter-over-quarter.
- 95 funds opened new GSK positions in Q4 2013 and 38 closed out, a net change of +57 holders.
- The largest GSK buyer in Q4 2013 was Bank of America, an estimated $267M added.
- The largest GSK seller in Q4 2013 was Fidelity Investments, an estimated $186M sold.
Based on aggregated 13F filings for Q4 2013.